发明名称 Use of quinoxalines in combination with protease inhibitors as medicament for treatis aids and/or hiv infections
摘要 Medicaments comprising, in combination, (a) one or more protease inhibitors and (b) one or more cpds. of formula (I) (or their tautomers of formula (Ia)) are new: n = 0-4; R<1> = F, Cl, Br, I, CF3, CF3O, OH, 1-8C alkyl, Cya, TO, TO-R<1>O, TS, TSO, TSO2, NO2, NH2, N3, NHT, NT2, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpiperazinyl, thiomorpholino, imidazolyl, triazolyl, tetrazolyl, Ac, AcO, AcNH, CN, CONH2, COOH, TOCO, HOSO2 or SO2NH2; or Ph, PhO, PhOCO, PhS, PhSO, PhSO2, PhOSO2, PhSO2O, anilinosulphonyl, PhSO2NH, PhCO, 2-, 3- or 4-pyridyl (all opt. substd. by &le; 5 R<6>); T = 1-6C alkyl; Cya = 5-8C cycloalkyl; R<1> = 1-4C alkylene; R<6> = F, Cl, Br, I, CN, CF3, CF3O, NO2, NH2, N3, T, Cy, TO, TS, TSO, TSO2, TNH, T2N, TOCO, Ph, PhO or 2-, 3- or 4-pyridyl; R<2>,R<5> = H, OH, TO, ArO, AcO, CN, NH2, TNH, T2N, ArNH or AcNH; 1-8C alkyl, 2-8C alkenyl, 3-8C alkynyl, Cy, Cy', Cy-R<1>, Cy'-R<1> or TCO (all opt. substd. by F, Cl, Br, I, CN, NH2, SH, OH, AcO, PhCOO, PhCH2O, PhO, TO, TNH, T2N, TS, TSO2, PhSO2, oxo, thioxo, carboxy or carbamoyl); 3-8C alkenyl, 2-8C alkenylcarbonyl, CyCO, Cy''CO, Cy-(1-3C alkyl)carbonyl, 5-6C cycloalkenyl- (1-3C alkyl)carbonyl, 1-8C alkenyloxycarbonyl, 2-8C alkynyloxycarbonyl, 1-8C alkylthiocarbonyl, 2-8C alkenylthiocarbonyl, 1-8C alkylaminocarbonyl, di(1-8C alkyl)aminocarbonyl, TSO2, 2-6C alkenylsulphonyl, 2-8C alkenylaminocarbonyl or di((2-6C)alkenyl)- aminocarbonyl (all opt. substd. by F, Cl, OH, RO, oxo or phenyl); 1-8C alkoxycarbonyl (opt. substd. by F, Cl, Br, OH, RO, RNH, (R)2N or RS); pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl- or 4-methylpiperazin-1-yl-carbonyl (all opt. substd. by R, 2-6C alkenyl, 1-4C acyl, oxo, thioxo, carboxy or phenyl); Ar, ArCO, ArCS, ArS-CO, ArS-CS, ArOCO, ArSO2, ArNHCO, ArNHCS, aryl(1-5C)alkylaminocarbonyl, Ar', arylalkenyl, arylalkynyl, Ar'CO, arylalkenylcarbonyl, Ar'OCO or Ar'SCO (all opt. substd. by 1-5 R<6>); or Het, Het', Het-alkenyl, Het'CO, Het-alkenylcarbonyl, HetOCO, HetSCO, HetNHCO, Het'OCO, Het'SCO or Het'NHCO (all opt. substd. by 1-3 R<6>); Ar = aryl; Ar' = aryl(1-5C)alkyl; Het = heteroaryl; Het' = heteroaryl(1-3C)alkyl; R = 1-4C alkyl; Ac' = 1-6C acyl; Ph = phenyl; Cy = 3-8C cycloalkyl; Cy' = 3-8C cycloalkenyl; Cy'' = 5-8C cycloalkenyl; R<3>, R<4> = H; 1-8C alkyl, 2-8C alkenyl, Cy or Cy' (all opt. substd. by F, Cl, OH, NH2, SH, Ac'O, PhCOO, PhCH2O, PhO, RO, RNH, (R)2N, RS, RSO2, RSO, COOH or CONH2); Ar, aryl(1-3C)alkyl, Het or Het' (all opt. substd. by &le; 5 R<6>); or R<3>+R<4> or R<3>+R<5> can be part of an unsatd. or satd. carbo- or heterocyclic ring of 3-8 atoms, which is opt. substd. by F, Cl, OH, NH2, T, 2-6C alkenyl, TO, 2-6C alkynyl, 1-6C acyloxy, benzoyloxy, oxo, thioxo, COOH, CONH2 or Ph); Ac' = 1-4C acyl; X = O, S, Se or NR<2>; with the exception of cpds. in which (a) R<3> and R<4> are both H, (b) R<2> and R<5> are H and R<3> and R<4> are arylalkyl, and (c) X is O and R<2> and R<3> are H.
申请公布号 ZA9601516(B) 申请公布日期 1996.09.03
申请号 ZA19960001516 申请日期 1996.02.26
申请人 BAYER AKTIENGESELLSCHAFT. 发明人 ARNOLD PAESSENS;MARTIN BLUNCK;GUENTHER REISS;JOERG-PETER KLEIM;MANFRED ROESNER
分类号 C12N9/99;A61K31/34;A61K31/365;A61K31/425;A61K31/44;A61K31/47;A61K31/495;A61K31/55;A61K38/55;A61K45/00;A61K45/06;A61P31/12;A61P31/18;A61P37/04;C07D241/44 主分类号 C12N9/99
代理机构 代理人
主权项
地址